Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 851,929 | 871,668 | 966,777 | 1,038,624 | 868,565 |
| Marketable Securities | 1,008,786 | 1,010,429 | 1,022,597 | 1,033,860 | 1,059,454 |
| Receivables | 236,808 | 223,836 | 214,628 | 201,509 | 203,854 |
| Inventories | 226,876 | 202,675 | 203,968 | 221,192 | 208,095 |
| Other current assets | 148,215 | 179,769 | 149,891 | 130,744 | 129,332 |
| TOTAL | $2,472,614 | $2,488,377 | $2,557,861 | $2,625,929 | $2,469,300 |
| Non-Current Assets | |||||
| PPE Net | 188,874 | 182,862 | 180,037 | 181,005 | 183,292 |
| Intangibles | 0 | 0 | 0 | 13,057 | 13,062 |
| Other Non-Current Assets | 464,402 | 388,547 | 390,468 | 336,158 | 331,199 |
| TOTAL | $653,276 | $571,409 | $570,505 | $530,220 | $527,553 |
| Total Assets | $3,125,890 | $3,059,786 | $3,128,366 | $3,156,149 | $2,996,853 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 109,796 | 106,710 | 95,875 | 118,461 | 56,207 |
| Accrued Expenses | 326,877 | 345,554 | 418,996 | 368,998 | 383,699 |
| Other current liabilities | 16,992 | 17,381 | N/A | 26,213 | 16,416 |
| TOTAL | $498,654 | $536,884 | $619,604 | $602,916 | $545,566 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,235,517 | 1,234,284 | 1,544,292 | 1,542,770 | 1,100,873 |
| Deferred Revenues | 44,989 | 67,239 | 89,244 | 89,244 | 89,244 |
| Other Non-Current Liabilities | 165,308 | 90,869 | 94,520 | 72,129 | 93,968 |
| TOTAL | $1,885,825 | $1,810,153 | $2,123,812 | $2,122,393 | $1,724,830 |
| Total Liabilities | $2,384,479 | $2,347,037 | $2,743,416 | $2,725,309 | $2,270,396 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,279 | 93,149 | 87,982 | 87,783 | 87,568 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -4,450,931 | -4,426,991 | -3,910,236 | -3,800,992 | -3,543,254 |
| Other shareholders' equity | -1,055 | -419 | -1,664 | -3,205 | -2,485 |
| TOTAL | $741,411 | $712,749 | $384,950 | $430,840 | $726,457 |
| Total Liabilities And Equity | $3,125,890 | $3,059,786 | $3,128,366 | $3,156,149 | $2,996,853 |